Mark Mikola
Papers
1
Total Citations
110
H-Index
1
About
Mark Mikola is a leading figure in bioprocess engineering, whose work has fundamentally advanced the high-throughput development of mammalian cell cultures. His research centers on the scalability and reproducibility of micro-bioreactor systems, addressing a critical bottleneck in the production of therapeutic proteins and vaccines. Mikola’s most influential contribution, his 2010 paper on a novel micro-bioreactor technology for fed-batch CHO cultures, has garnered over 110 citations and is considered a seminal work in the field. This study provided the first rigorous demonstration that small-scale, automated systems could reliably predict the performance of larger, conventional bioreactors, thereby enabling researchers to conduct far more experiments in parallel. By validating that these micro-scale platforms are both scalable and reproducible, Mikola’s work has empowered the biopharmaceutical industry to dramatically accelerate process development timelines, reduce costs, and explore a wider design space for optimizing cell culture productivity. His achievements have established a new standard for early-stage bioprocess characterization, making him a key innovator in the push for faster, more efficient drug development.
Research Focus
Key Achievements
Top Papers
- 1